DCGI Issues Advisory Against Digene Gel

DCGI issues advisory against antacid 'Digene Gel'

Drug Controller General of India (DCGI) Rajeev Singh Raghuvanshi has issued an advisory to discontinue the use of antacid Digene Gel manufactured by drugmaker Abbott India at its Goa unit. Sep 6, 2023
IPO

The 10 Most Highly Anticipated Public Listings of 2023

As we venture further into 2023, the financial world sits on the edge of its seat, eagerly awaiting a series of highly anticipated Initial Public Offerings (IPOs). Several innovative, rapidly growing companies across industries such as technology, biotech, and green energy, are predicted to make their debut on the stock market. Aug 16, 2023